In a first, the Food and Drug Administration on Friday approved AstraZeneca's FluMist, a nasal spray flu vaccine that anyone ...

FLUMIST ® has been approved in the US as the only self-administered influenza vaccine. FLUMIST, a needle-free nasal spray, was approved to be self-administered by adults up to 49 years of age or ...

In a first, the US Food and Drug Administration on Friday approved a nasal spray flu vaccine for self-administration.

Instead of four equal quarterly distributions, AstraZeneca insists on two payments per year, with a greater portion announced ...

Two-time winners Korea DPR and 2018 champions Japan begin their Colombia 2024 campaigns; Argentina and the Netherlands also in action. The match schedule and kick-off times for the FIFA U-20 Women ...

Since GSK’s Nucala and AstraZeneca’s Fasenra were approved two years apart ... Nucala gained nods from the FDA to treat ...

Two of the simplest ways to measure the success of companies that develop and commercialize drugs is to count their approvals ...

Chinese authorities are looking into the company’s collection of patient data to assess whether it infringed on data privacy ...

Datopotamab deruxtecan, developed under a collaboration between AstraZeneca and Daiichi Sankyo, elicited higher overall ...

In this article, we are going to take a look at where AstraZeneca PLC (NASDAQ ... and is forecasted to exceed $300 billion by 2032. In 2020, approximately 19.3 million new cancer cases and about ...